Effect of Alemtuzumab on Intestinal Intraepithelial Lymphocytes and Intestinal Barrier Function in Cynomolgus Model
Background: Alemtuzumab has been used in organ transplantation and a variety of hematologic malignancies (especially for the treatment of B-cell chronic lymphocytic leukemia). However, serious infectious complications frequently occur after treatment. The reason for increased infections postalemtuzu...
Main Authors: | Lin-Lin Qu, Ya-Qing Lyu, Hai-Tao Jiang, Ting Shan, Jing-Bin Zhang, Qiu-Rong Li, Jie-Shou Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2015-01-01
|
Series: | Chinese Medical Journal |
Subjects: | |
Online Access: | http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=5;spage=680;epage=686;aulast=Qu |
Similar Items
-
Dynamics and clinical significance of intestinal intraepithelial lymphocytes
by: Hayakazu Sumida
Published: (2019-07-01) -
The Neonatal Development of Intraepithelial and Lamina Propria Lymphocytes in the Murine Small Intestine
by: Jessica C. A. Ter Steege, et al.
Published: (1997-01-01) -
IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB
by: M. N Khorobrykh, et al.
Published: (2014-07-01) -
Intraepithelial T Cells Diverge by Intestinal Location as Pigs Age
by: Jayne E. Wiarda, et al.
Published: (2020-06-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)